Optimata Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 3

Optimata General Information

Description

Operator of a bio-pharmaceutical company aiming at accelerating the long and costly process of drug development. The company provides computer technologies for predicting improved patient therapy high level multi-scale modeling that integrates rational analysis of treatment mechanism of action and efficacy, together with information from large data bases, enabling patients receive the best drug therapy thus facilitating improved treatment decisions in malignant diseases.

Contact Information

Website
www.optimata.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • Hate'ena St.
  • Bnei Atarot 60991
  • Israel
+972
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
TMT, HealthTech
Corporate Office
  • Hate'ena St.
  • Bnei Atarot 60991
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optimata Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Optimata‘s full profile, request access.

Request a free trial

Optimata Patents

  • 35

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • Pending

  • Expiring in next 12 mo

Optimata Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200321091-A1 System and method for prediction of medical treatment effect Inactive 25-Oct-2017
EP-3701544-A1 System and method for prediction of medical treatment effect Inactive 25-Oct-2017
EP-3103096-A1 Method and system for prediction of medical treatment effect Inactive 04-Feb-2014
EP-3103096-A4 Method and system for prediction of medical treatment effect Inactive 04-Feb-2014
US-20110286960-A1 Cancer therapy by docetaxel and granulocyte colony-stimulating factor (g-csf) Inactive 02-Nov-2008 A61K45/06
To view Optimata’s complete patent history, request access »

Optimata Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Optimata Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Optimata‘s full profile, request access.

Request a free trial

Optimata FAQs

  • When was Optimata founded?

    Optimata was founded in 2000.

  • Where is Optimata headquartered?

    Optimata is headquartered in Bnei Atarot, Israel.

  • What is the size of Optimata?

    Optimata has 11 total employees.

  • What industry is Optimata in?

    Optimata’s primary industry is Discovery Tools (Healthcare).

  • Is Optimata a private or public company?

    Optimata is a Private company.

  • What is Optimata’s current revenue?

    The current revenue for Optimata is .

  • How much funding has Optimata raised over time?

    Optimata has raised $1.5M.

  • Who are Optimata’s investors?

    Israel Innovation Authority has invested in Optimata.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »